Ovid Therapeutics to Participate in Upcoming Investor Conferences
Ovid Therapeutics (US:OVID) Globenewswire·2026-02-25 12:00NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines to treat brain disorders and symptoms caused by excess neural excitability, today announced that the Company’s management will participate in three upcoming investor conferences: Oppenheimer 36th Annual Healthcare Life Sciences Conference – Wednesday, February 25th at 11:20 am ET46th Annual TD Cowen Health Care Conference – Wednesday, March 4th at 9:50 am ETLeeri ...